71 related articles for article (PubMed ID: 8920763)
1. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators.
Kopreski MS; Witters L; Brennan WA; Buckwalter EA; Chinchilli VM; Demers LM; Lipton A
Anticancer Res; 1996; 16(5B):3037-41. PubMed ID: 8920763
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
Ottenhoff-Kalff AE; Rijksen G; van Beurden EA; Hennipman A; Michels AA; Staal GE
Cancer Res; 1992 Sep; 52(17):4773-8. PubMed ID: 1380891
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosyl-proteins in human breast cancer.
Partanen S
Anticancer Res; 1993; 13(5C):1777-80. PubMed ID: 7505541
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.
Hennipman A; van Oirschot BA; Smits J; Rijksen G; Staal GE
Cancer Res; 1989 Feb; 49(3):516-21. PubMed ID: 2910471
[TBL] [Abstract][Full Text] [Related]
5. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities].
Spyratos F; Romain S; Rostaing-Puissant B; Daver A; Collona M; Descotes F; Martin PM; Bougnoux P; Roth H; Bolla M
Bull Cancer; 1999; 86(7-8):678-84. PubMed ID: 10477385
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer.
Lüftner D; Mazurek S; Henschke P; Mesterharm J; Schildhauer S; Geppert R; Wernecke KD; Possinger K
Anticancer Res; 2003; 23(2A):991-7. PubMed ID: 12820337
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
8. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
10. Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor suppressor role in colorectal mucosal cells.
Partanen S
Anticancer Res; 1996; 16(2):943-6. PubMed ID: 8687156
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
[TBL] [Abstract][Full Text] [Related]
12. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
Mansour OA; Zekri AR; Harvey J; Teramoto Y; el-Ahmady O
Anticancer Res; 1997; 17(4B):3101-6. PubMed ID: 9329611
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
14. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].
Chassevent A; Jourdan ML; Ferrero-Poüs M; Colonna M; Romain S; Spyratos F; Roth H; Bolla M
Bull Cancer; 1999; 86(7-8):685-91. PubMed ID: 10477386
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.
Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G
Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
17. NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.
Molina MA; Sáez R; Ramsey EE; Garcia-Barchino MJ; Rojo F; Evans AJ; Albanell J; Keenan EJ; Lluch A; García-Conde J; Baselga J; Clinton GM
Clin Cancer Res; 2002 Feb; 8(2):347-53. PubMed ID: 11839648
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
[TBL] [Abstract][Full Text] [Related]
19. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.
Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL
Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
